(Q36250930)

English

Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cost-benefit comparison of two proposed overseas programs for reducing chronic Hepatitis B infection among refugees: is screening essential? (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Julie A Gazmararian

3

object named as

Julie Gazmararian

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Amelia Jazwa

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Margaret S Coleman

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

La'Marcus T Wingate

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Brian Maskery

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Tarissa Mitchell

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Michelle Weinberg

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

14 January 2015

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

33

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1393-1399

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Valuing vaccines using value of statistical life measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Hepatitis B screening and vaccination strategies for newly arrived adult Canadian immigrants and refugees: a cost-effectiveness analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Chronic hepatitis B infection: a workshop consensus statement and algorithm.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

The cost-effectiveness of screening for chronic hepatitis B infection in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

A simulation shows that early treatment of chronic hepatitis B infection can cut deaths and be cost-effective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Is chronic hepatitis B being undertreated in the United States?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Hepatitis B: diagnosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Liver cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Hepatitis B virus infection: epidemiology and vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Hepatitis B virus: inactive carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Global epidemiology of hepatitis B virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Natural history of hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

Prevalence of tuberculosis, hepatitis B virus, and intestinal parasitic infections among refugees to Minnesota

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

1 October 2017

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.010

7 January 2021

Cost effectiveness of screening immigrants for hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

22 September 2018

Hepatitis B virus infection among refugees resettled in the U.S.: high prevalence and challenges in access to health care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

22 September 2018

Treatment alternatives for hepatitis B cirrhosis: a cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

22 September 2018

Cost of chronic hepatitis B infection in the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

22 September 2018

Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4633992

22 September 2018

Sero-epidemiology of hepatitis B among new refugees to Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.010

7 January 2021

Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.010

7 January 2021

Cost-effectiveness of hepatitis B serology testing before hepatitis B vaccination in the Akha tribal children in northeastern Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.01.010

7 January 2021

Cost of vaccinating refugees overseas versus after arrival in the United States, 2005

1 reference

https://pubmed.ncbi.nlm.nih.gov/25595868

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2015.01.010

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36250930&oldid=1981480516"